SBIR/STTR Research Award
Novel Immunotherapy for Hepatocellular Carcinoma
Award amount
$100,005Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Panorama Research Incorporated
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- LYVHC3ARFRJ7
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) is one the most common forms of cancer worldwide, with approximately 1,000,000 new cases and 1,300,000 deaths reported annually. It is one of the most lethal forms of cancer, in part d
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel Therapy for Sarcopenia
- Novel therapy to prevent alveolar bone loss in severe periodontitis
- Novel therapy for arthrofibrosis
- Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
- Monoclonal antibody for autoimmune disease
Research funding history
149 SBIR/STTR records share this UEI (1990–2025). Reported award amounts total $35,373,004. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Agriculture, National Science Foundation